| Date | Title | Description |
| 12.06.2025 | Autonomize AI Raises $28M Series A to Scale Agentic AI for Healthcare and Life Sciences | What You Should Know:
– Autonomize AI, a pioneer in AI-driven healthcare solutions, today announced that it raised $28 million in a Series A funding, bringing total capital raised to $32 million to date.
– The round was led by Valtruis, The... |
| 09.04.2021 | Carta Healthcare Raises $17.3M for AI-Assisted Data Abstraction | What You Should Know:
– Carta Healthcare, a provider of AI-powered clinical data abstraction technology and services, is pleased to announce a recent $17.3M Series A investment led by Storm Ventures. AI Digital Innovation Fund (affiliated w... |
| 12.08.2020 | Reify Health Raises $30M to Fix The Broken Clinical Trial Ecosystem | What You Should Know:
– Reify Health, a clinical trial software provider that digitizes and accelerates clinical trials is announcing a $30 million series B funding round to support the company’s ambitious mission to fix the broken clinical... |
| 01.07.2016 | With devaluation, Zenefits tries to bounce back from scandal | David Sacks
Zenefits, the online human resources and benefits company, downsized its stock valuation as its executives forged a deal this week to avoid investor lawsuits.
In the revaluation, the onetime Silicon Valley darling allowed large ... |
| 14.03.2016 | Daily funding roundup - March 14, 2016 | LendInvest raised $25M; GV led $21M investment in Epigenetix; Arterys closed a $12M funding
LendInvest, a platform for peer-to-peer real estate investing, closed a £17 million (approximately $25 million) Series B funding round from Atomico,... |
| 16.01.2016 | 4 investors share insights on health tech from J.P. Morgan that will shape 2016 | Adam Goulburn, a partner at Lux Capital, met the physician who would be his wife at the J.P. Morgan Healthcare Conference a few years back. Wonder how often that happens? An Australian, Goulburn was a Postdoctoral Fellow in neuroscience at ... |
| 09.01.2016 | Highlights from CES and the demise of HealthSpot: 5 must-read stories from MedCity News this week | Watch the archived video above, and also check out five important stories we covered this week – the first of which being the center of our MedHeads discussion:
1. Why did HealthSpot fail? The telemedicine industry weighs in.
Was HealthSpot... |
| 06.01.2016 | Why did HealthSpot fail? The telemedicine industry weighs in | It’s left to others to speculate.
Was HealthSpot mismanaged? Were freestanding kiosks too expensive, 1990s technology in a world of 2010s smartphones? Did HealthSpot pick the wrong revenue model? Opinions vary.
What’s known is that, accordi... |
| 11.12.2015 | Daily funding roundup - December 11, 2015 | SteelHouse secured $49M; BlackBuck raised $25M; Oncam acquired $7M funding
Bangalore-based OnlineRTI, an online service to file Right to Information (RTI) applications, has raised about $150,000 (INR 1 Cr.) in an angel round of funding from... |
| 17.07.2015 | 6 tips for hackers in healthcare | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today!
Since I first started investing in digital health... |
| 17.07.2015 | 6 tips for hackers in healthcare | Since I first started investing in digital health in 2007, the sector has exploded. Digital health startups raised over $4 billion in venture capital in 2014 and will likely raise even more this year. Based on my observations, a large propo... |
| 05.03.2015 | Stanford Health Care and GE Ventures form new company to validate and optimize digital health technology | To illustrate the growth of digital health tools, a Rock Health report released earlier this year said more than $4 billion in venture funding was invested in over 250 digital health companies in 2014 alone.
Evidation raised $6.2 million in... |
| 05.09.2014 | B2B2C or direct to consumer: Which telemedicine model will win? | There have also been some barriers impeding growth. Ezra Mehlman of Health Enterprise Partners pointed out that the inability to grow small businesses has historically posed a big barrier to entry in the market. “Regulations that impede int... |
| 19.03.2014 | Healthcare startups got 40% of the $1B invested in Internet of Things ideas last year | Orthosensor is a medical device that transmits information to orpthopedic surgeons in real time to let them know whether knee replacements are implanted the right way to reduce the need for additional surgery. It also is intended to extend ... |
| 31.01.2014 | Educated guesstimates about the Audax Health price tag start at $100M and rise to $400M+ | Setting aside the company’s web-based platform, Audax’s high-powered board probably didn’t hurt in getting the company to this point either. Its chairman is Richard Klaussner, who helped set up the Bill & Melinda Gates Foundation’s glob... |
| 12.11.2013 | Apple’s hidden threat to Fitbit, Jawbone UP, and Nike Fuel | Did you miss a session from GamesBeat Summit 2022? All sessions are available to stream now. Learn more.
Skip Fleshman is a partner at Asset Management Ventures
Much has been made of the iPhone 5S’s new A7 chip, but the new M7 co-processor ... |
| 12.11.2013 | Apple’s hidden threat to Fitbit, Jawbone UP, and Nike Fuel | Skip Fleshman is a partner at Asset Management Ventures
Much has been made of the iPhone 5S’s new A7 chip, but the new M7 co-processor is, if anything, potentially more disruptive. The M7 will have an impact on the entire development proces... |
| 02.06.2013 | Why VCs should love hardware startups | Skip Fleshman is a partner at Asset Management Ventures.
Venture capitalists hate investing in hardware startups for a myriad of reasons. Design and iteration are more difficult. Margins are low. Manufacturing issues are unpredictable. Inve... |
| 02.06.2013 | Why VCs should love hardware startups | Did you miss a session from GamesBeat Summit 2022? All sessions are available to stream now. Learn more.
Skip Fleshman is a partner at Asset Management Ventures.
Venture capitalists hate investing in hardware startups for a myriad of reason... |
| 25.04.2013 | Esperion Therapeutics Completes $33M Financing | Esperion Therapeutics, Inc., a Plymouth, MI-based clinical stage biopharmaceutical company, completed a $33m financing.
The round was led by new investor Longitude Capital, with participation from existing investors Aisling Capital, Alta Pa... |
| 21.04.2009 | Sonoma secures $12M to heal wrist, clavicle fractures | Sonoma Orthopedic, maker of a device used to mend wrist and clavicle fractures, has raised $12 million in a third round of funding to commercialize its first two products, reports VentureWire. Based in Santa Rosa, Calif., the company’s flag... |
| 17.04.2009 | iScience sees $20.5M for eye surgery instruments | iScience Interventional, maker of surgical tools for eye operations, has closed a prolonged sixth round of funding at $20.5 million after facing a bit more of a challenge due to the economic climate. The money will be used to commercialize ... |
| 15.04.2009 | Cancer drug maker BiPar sells to Sanofi-aventis for $500M | BiPar Sciences, maker of tumor-targeting cancer treatments, will be acquired by public global pharmaceutical company Sanofi-aventis. The two companies have signed a binding agreement that could deliver more than $500 million to BiPar, divid... |
| 05.02.2009 | Napo Pharm raises seed money for its anti-diarrheal drug | Napo Pharmaceuticals, a South San Francisco-based drug company, just closed a round of initial funding from Asset Management. The undisclosed sum is earmarked for its subsidiary Crofelemer Access Program Global, which makes an anti-diarrhea... |
| 13.01.2009 | BiPar snags $20M for inhibitor-based cancer therapies | Pharmaceutical firm BiPar Sciences just brought in $20 million in private equity and venture debt to advance its lead therapy, targeting breast cancer, to phase-three clinical trials. The investment will double the Brisbane, Calif.-based co... |
| 04.08.2008 | Ahead of deployment, Brilliant Telecom adds to its round | Sometimes a funding is all about timing. In Brilliant Telecommunications‘ case, everything it does is about timing. The Campbell, Calif.-based company makes timing devices for the telecom industry.
Gearing up for its deployment of wireless ... |
| 18.06.2008 | Biomimedica raises $2.4 million for joint repairs | Biomimedica has raised $2.4 million in a first round for its joint-repair business.
VentureWire reported that Emergent Medical Ventures led the round. Other investors include Asset Management Co. and Life Science Angels.
Based in Santa Clar... |
| 20.07.2007 | Novocell: With diabetes study pending, investors pony up another $25M | Novocell, a San Diego embryonic stem-cell company, raised $25 million in a third round of funding. That’s presumably a bit of a letdown for the company, which had previously hoped to pull in as much as $35 million in the round. I wrote earl... |
| 29.06.2007 | Koronis: Mutating HIV into extinction | (UPDATED: See below.)
Seattle’s Koronis Pharmaceuticals, a biotech focused on antiviral drugs that cleverly attempt to to drive viruses into extinction, got some serious validation yesterday when it raised $20 million to fund a mid-stage “p... |
| 21.05.2007 | Sonoma Orthopedics raises at least $10M for spinal devices | Sonoma Orthopedics, a stealthy spinal-device maker in Santa Rosa, Calif., raised at least $10 million in a second funding round, VentureWire reports. The company raised $3 million in a first round last April.
Sonoma Orthopedics is at work o... |
| - | Why did HealthSpot fail? The telemedicine industry weighs in | In the wake of the news that HealthSpot has ceased operations, the kiosk-based telehealth service provider is remaining mum, but others in the industry remain bullish on video consults.
So far, attempts to reach HealthSpot CEO Steve Cashman... |
| - | Educated guesstimates about the Audax Health price tag start at $100M and rise to $400M+ | UnitedHealth Group’s (NYSE: UNH) move to acquire Audax Health Solutions, through its Optum subsidiary, has generated a lot of interest as investors seek to develop a better understanding of how much (or how little) payers value consumer tec... |
| - | Highlights from CES and the demise of HealthSpot: 5 must-read stories from MedCity News this week | We had a particularly lively MedHeads discussion this week – in that it was live from the International Consumer Electronics Show (CES) in Las Vegas, with MedCity News reporter Stephanie Baum reporting on site. Reporter Neil Versel joined t... |
| - | Healthcare startups got 40% of the $1B invested in Internet of Things ideas last year | The Internet of Things was a hot area for investment last year. Of the 153 deals raising $1 billion from venture capitalists, a big fat slice — 61 — were healthcare IT companies and health and wellness businesses, according to CB Insights.
... |
| - | 4 questions raised by Castlight Health IPO filing | Castlight Health surprised a few with its lackluster, albeit growing, revenues in its filing for an initial public offering this week. But despite what seems like a pretty big overvaluation in a leaked report that valued the digital health ... |
| - | Stanford Health Care and GE Ventures form new company to validate and optimize digital health technology | The interest in adopting digital health tools such as clinical wearables and smartphone diagnostics has been hindered in some ways by the rapid growth in the number of these devices and relatively little clinical validation. GE Ventures and... |
| - | Carta Healthcare Raises $25M for AI-Powered Clinical Data Abstraction | What You Should Know:
What You Should Know:
Carta Healthcare®, a company whose mission is to improve patient care by harnessing the value of clinical data, announced today the final closing of its $25 million series B financing, thanks to a... |
| - | 4 investors share insights on health tech from J.P. Morgan that will shape 2016 | It’s been a frenetic couple of weeks between Consumer Electronics Show and J.P. Morgan Healthcare conference so now it’s time to take a broader look at what investors took away from them. The latter conference has certainly evolved since it... |
| - | With devaluation, Zenefits tries to bounce back from scandal | David Sacks
Zenefits, the online human resources and benefits company, downsized its stock valuation as its executives forged a deal this week to avoid investor lawsuits.
In the revaluation, the onetime Silicon Valley darling allowed large ... |
| - | B2B2C or direct to consumer: Which telemedicine model will win? | Looking over the year’s telemedicine deals, it seems like investors are hedging their bets. Although tools supported by employer plans have dominated, direct to consumer models are proving attractive too, as are more specialized business to... |
